Citigroup Inc G1 Therapeutics, Inc. Transaction History

Citigroup Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$2.2 - $4.98 $260,326 - $589,283	-118,330 Reduced 91.68%	10,736 $24,000
Q1 2024 May 10, 2024	BUY	$2.1 - $4.83 $90,545 - $208,255	43,117 Added 50.17%	129,066 $557,000
Q4 2023 Feb 09, 2024	BUY	$1.12 - $3.73 $95,542 - $318,191	85,306 Added 13266.87%	85,949 $262,000
Q3 2023 Nov 09, 2023	SELL	$1.22 - $2.67 $284 - $622	-233 Reduced 26.6%	643 $0
Q2 2023 Aug 10, 2023	SELL	$2.46 - $3.14 $1,916 - $2,446	-779 Reduced 47.07%	876 $2,000
Q1 2023 May 11, 2023	SELL	$2.57 - $8.16 $58,464 - $185,631	-22,749 Reduced 93.22%	1,655 $4,000
Q4 2022 Feb 09, 2023	SELL	$5.19 - $13.5 $534,076 - $1.39 Million	-102,905 Reduced 80.83%	24,404 $132,000
Q3 2022 Nov 10, 2022	BUY	$5.17 - $16.99 $651,921 - $2.14 Million	126,097 Added 10404.04%	127,309 $1.59 Million
Q2 2022 Aug 10, 2022	SELL	$4.04 - $8.51 $165,001 - $347,565	-40,842 Reduced 97.12%	1,212 $6,000
Q1 2022 May 12, 2022	SELL	$7.6 - $11.02 $1.71 Million - $2.48 Million	-225,119 Reduced 84.26%	42,054 $320,000
Q4 2021 Feb 10, 2022	BUY	$10.16 - $16.17 $1.32 Million - $2.1 Million	129,616 Added 94.23%	267,173 $2.73 Million
Q3 2021 Nov 10, 2021	BUY	$13.16 - $22.47 $1.81 Million - $3.09 Million	137,557 New	137,557 $1.85 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.